NFKB1 and amyotrophic lateral sclerosis: Our group recently reported that neuron-specific expression of the super-repressor form of the NF-κB inhibitor reduced inflammation and mitigated ALS/FTLD-like pathological changes in mouse models of ALS and FTLD [9].